CLYM
Climb Bio
CLYM
CLYM
35 hedge funds and large institutions have $182M invested in Climb Bio in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
41% less capital invested
Capital invested by funds: $311M → $182M (-$129M)
Holders
35
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.12M | |
| 2 | +$494K | |
| 3 | +$405K | |
| 4 |
PL
Parkwood LLC
Cleveland,
Ohio
|
+$320K |
| 5 |
BlackRock
New York
|
+$254K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$960K | |
| 3 | -$268K | |
| 4 |
HF
HRT Financial
New York
|
-$212K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$145K |